24th Jul 2018 08:54
LONDON (Alliance News) - ConvaTec Group PLC said Tuesday it has secured US Food & Drug Administration 510(k) clearance for its Aquacel Ag Advantage dressing for wound management.
In clinical studies, ConvaTec's antimicrobial dressing demonstrated substantial wound improvements even in the most hard-to-heal wounds, it said.
Aquacel Ag Advantage dressing is currently available in markets across Europe and Asia Pacific, where it is marketed as Aquacel Ag+ Extra dressing. Commercial availability in the US is expected to commence alongside product evaluations in October.
Shares in the medical products and technologies company were up 0.9% at 207.00 pence each on Tuesday morning.
Related Shares:
ConvaTec